You are on Trendlyne United States.
Click here
to go to India website or make
United States
as your default
Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Data Downloader
Events Calendar
Explore
FAQs
Widgets
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Login / Sign up
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Alaunos Therapeutics Inc
Swot
Alaunos Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Alaunos Therapeutics Inc has 15 Strengths, 9 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(9)
Opportunity
(0)
Threats
(2)
Others
(0)
Price crossing above SMA20 today, and greater than SMA5
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Company with No Debt
Annual Net Profits improving for last 2 years
Increasing profits every quarter for the past 4 quarters
Top Gainers
Stock with Low PE (PE < = 10)
Biggest Price Gainers from Open
Highest Recovery from 52 Week Low
Promoter decreasing their shareholding
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
